Laura Fletcher, PhD

Laura Fletcher, PhD, is currently the Head of Business Development and Venture Portfolio for Pharma at Deep Science Ventures. Laura also holds director positions at Stratosvir Limited, Neobe Therapeutics, and Enedra Therapeutics. Previously, Laura worked at Cancer Research UK for ten years, holding various associate director roles. Laura also has experience as a Director at Cellinta Limited and various business development roles at Cancer Research Technology. Laura is a co-founder of ProXara Biotechnology Ltd and holds a PhD in Insulin signalling from the University of Bristol.